These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 17355203)
1. High capacity homogeneous non-radioactive cortisol detection assays for human 11beta-hydroxysteroid dehydrogenase type 1. Yu V; Tudor Y; Hale C; Plant M; Kim KW; Wang M; Nguyen Y; Miguel TS; Chen M; Nybo R; Baumgartner J; Kurzeja RJ; Powers D Assay Drug Dev Technol; 2007 Feb; 5(1):105-15. PubMed ID: 17355203 [TBL] [Abstract][Full Text] [Related]
2. High-throughput screening of 11beta-hydroxysteroid dehydrogenase type 1 in scintillation proximity assay format. Solly K; Mundt SS; Zokian HJ; Ding GJ; Hermanowski-Vosatka A; Strulovici B; Zheng W Assay Drug Dev Technol; 2005 Aug; 3(4):377-84. PubMed ID: 16180992 [TBL] [Abstract][Full Text] [Related]
4. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa. Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Wang M Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570 [TBL] [Abstract][Full Text] [Related]
6. The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1. Zhou HY; Hu GX; Lian QQ; Morris D; Ge RS Toxicology; 2012 Feb; 292(1):1-12. PubMed ID: 22154985 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye. Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581 [TBL] [Abstract][Full Text] [Related]
8. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? Anagnostis P; Katsiki N; Adamidou F; Athyros VG; Karagiannis A; Kita M; Mikhailidis DP Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056 [TBL] [Abstract][Full Text] [Related]
9. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target. Tomlinson JW Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis. Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082 [TBL] [Abstract][Full Text] [Related]
12. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes. Itoi S; Terao M; Murota H; Katayama I Biochem Biophys Res Commun; 2013 Oct; 440(2):265-70. PubMed ID: 24055708 [TBL] [Abstract][Full Text] [Related]
13. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening. Schuster D; Maurer EM; Laggner C; Nashev LG; Wilckens T; Langer T; Odermatt A J Med Chem; 2006 Jun; 49(12):3454-66. PubMed ID: 16759088 [TBL] [Abstract][Full Text] [Related]
14. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase inhibitors using liquid chromatography/tandem mass spectrometry detection. Xu R; Sang BC; Navre M; Kassel DB Rapid Commun Mass Spectrom; 2006; 20(11):1643-7. PubMed ID: 16636996 [TBL] [Abstract][Full Text] [Related]
15. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men. Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378 [TBL] [Abstract][Full Text] [Related]
16. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364 [TBL] [Abstract][Full Text] [Related]
17. An in vitro microdialysis methodology to study 11beta-hydroxysteroid dehydrogenase type 1 enzyme activity in liver microsomes. Sun L; Stenken JA; Yang AY; Zhao JJ; Musson DG Anal Biochem; 2007 Nov; 370(1):26-37. PubMed ID: 17765862 [TBL] [Abstract][Full Text] [Related]
18. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835 [TBL] [Abstract][Full Text] [Related]
19. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499. Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448 [TBL] [Abstract][Full Text] [Related]
20. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. Draper N; Stewart PM J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]